We provide genomic products that harness the power of cutting edge science and technology to deliver you the most accurate results.
BioFire Respiratory 2.1 (RP2.1) panel
One Test and 22 Targets
The BioFire RP2.1 Panel uses a syndromic approach to accurately detect and identify the pathogens most commonly associated with respiratory infections. Rapid respiratory PCR test results may enable better-informed diagnosis and treatment of patients.
The BioFire® FilmArray® Gastrointestinal (GI) Panel
With overlapping symptoms, distinguishing possible causes of gastroenteritis can be challenging for any clinician. To further complicate diagnosis, traditional testing methods are slow, labor intensive, and fail to reveal the etiology of a patient’s gastrointestinal symptoms.1 Fortunately, syndromic testing from the BioFire GI Panel eliminates limitations from conventional methods by providing, faster, more accurate, and comprehensive results.
22 Targets. 1 Test
The FDA-cleared BioFire GI Panel tests for 22 of the most common pathogens associated with gastroenteritis—all from one patient sample and one easy to use reagent, with results available in about one hour.